GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » 3-Year EBITDA Growth Rate

Herantis Pharma (OHEL:HRTIS) 3-Year EBITDA Growth Rate : 34.50% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Herantis Pharma 3-Year EBITDA Growth Rate?

Herantis Pharma's EBITDA per Share for the six months ended in Dec. 2024 was €-0.11.

During the past 12 months, Herantis Pharma's average EBITDA Per Share Growth Rate was -1461.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Herantis Pharma was 70.00% per year. The lowest was -95.50% per year. And the median was 1.70% per year.


Competitive Comparison of Herantis Pharma's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Herantis Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Herantis Pharma's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Herantis Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Herantis Pharma's 3-Year EBITDA Growth Rate falls into.


;
;

Herantis Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Herantis Pharma  (OHEL:HRTIS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Herantis Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Herantis Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Herantis Pharma Business Description

Traded in Other Exchanges
N/A
Address
Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.

Herantis Pharma Headlines

No Headlines